Search
for
Sort by
Research 841–870 of 1000+
- Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- The Therapeutic Effect and the Changed Serum Zinc Level after Zinc Supplementation in Alopecia Areata Patients Who Had a Low Serum Zinc Level
- Therapeutic inhibition of keratinocyte TRPV3 sensory channel by local anesthetic dyclonine
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- Aromatase inhibitor–induced hair loss in two adolescents
- Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy
- Synergistic therapeutic effect of systemic steroids and dithranol in a patient of alopecia totalis—A case report
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Platelet-Therapeutics to Improve Tissue Regeneration and Wound Healing—Physiological Background and Methods of Preparation
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- 6-Gingerol inhibits hair cycle via induction of MMP2 and MMP9 expression
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Recent therapeutic developments for acne
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Clinical use of 5α-reductase inhibitors
- Effects of 5-alpha reductase inhibitors
- Contraindicated use of 5-alpha-reductase inhibitors in women
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study